Skip to main content
. 2016 May 2;7(23):35257–35269. doi: 10.18632/oncotarget.9135

Figure 6. Clinical relevance of miR-592, WSB1 and HIF-1a expression in patients with HCC.

Figure 6

A. Representative images of IHC staining for WSB1 and HIF-1a in HCC patients with high and low miR-592 expression. B. Correlationship between miR-592 expression and WSB1 and HIF-1a expression in HCC patients tissues. The effect of miR-592 and CoCl2 on C. SK-Hep-1 cell proliferation and D. cell cycle progression. E. Schematic diagram of the regulatory pathway from miR-592/WSB1 / HIF-1a axis to glycolysis in HCC. The mean and SD of three independent experiments performed in triplicate are shown.